Citizens & Northern Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$403K Sell
336
-53
-14% -$54.2K 0.09% 97
2026
Q1
$358K Buy
389
+74
+23% +$75K 0.09% 103
2025
Q4
$339K Buy
315
+33
+12% +$31.6K 0.08% 107
2025
Q3
$215K Hold
282
0.05% 117
2025
Q2
$220K Sell
282
-53
-16% -$41.2K 0.06% 114
2025
Q1
$277K Sell
335
-39
-10% -$32.5K 0.08% 106
2024
Q4
$289K Buy
374
+96
+35% +$79.5K 0.08% 109
2024
Q3
$246K Hold
278
0.07% 115
2024
Q2
$252K Hold
278
0.08% 109
2024
Q1
$216K Sell
278
-125
-31% -$89K 0.07% 107
2023
Q4
$235K Sell
403
-5
-1% -$2.92K 0.08% 109
2023
Q3
$219K Buy
+408
New +$210K 0.09% 95
2022
Q4
Sell
-630
Closed -$204K 100
2022
Q3
$204K Sell
630
-35
-5% -$11.1K 0.1% 93
2022
Q2
$216K Sell
665
-6,302
-90% -$1.89M 0.09% 100
2022
Q1
$2M Sell
6,967
-812
-10% -$209K 0.74% 31
2021
Q4
$2.15M Sell
7,779
-2,662
-25% -$675K 0.77% 30
2021
Q3
$2.41M Sell
10,441
-431
-4% -$106K 0.93% 24
2021
Q2
$2.5M Sell
10,872
-657
-6% -$132K 0.94% 24
2021
Q1
$2.15M Buy
11,529
+55
+0.5% +$10.8K 0.85% 33
2020
Q4
$1.94M Buy
11,474
+16
+0.1% +$2.39K 0.85% 34
2020
Q3
$1.7M Sell
11,458
-48
-0.4% -$7.43K 0.9% 35
2020
Q2
$1.89M Sell
11,506
-809
-7% -$124K 0.92% 32
2020
Q1
$1.71M Buy
12,315
+1,627
+15% +$224K 1.07% 29
2019
Q4
$1.41M Buy
10,688
+4,321
+68% +$501K 0.7% 48
2019
Q3
$712K Buy
+6,367
New +$709K 0.39% 62

Other funds holding LLY

Citizens & Northern Corp's LLY Position: Q2 2026 in Review

Citizens & Northern Corp reduced its Eli Lilly (LLY) stake by 14% in Q2 2026, selling an estimated $54.2K and leaving 336 shares worth $403K. The position accounts for 0.09% of the portfolio, ranked #97.

Citizens & Northern Corp first reported a position in LLY in Q3 2019 and has held it in 25 quarters since. The position peaked at $2.5M in Q2 2021. 961 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Citizens & Northern Corp held 336 shares of Eli Lilly worth $403K as of Q2 2026.
  • Citizens & Northern Corp sold 53 Eli Lilly shares in Q2 2026, an estimated $54.2K.
  • Eli Lilly made up 0.09% of Citizens & Northern Corp's portfolio in Q2 2026, its #97 holding.
  • Citizens & Northern Corp first reported a position in Eli Lilly in Q3 2019 and has held it in 25 quarters since.
  • Citizens & Northern Corp's Eli Lilly position peaked at $2.5M in Q2 2021.
  • 961 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Citizens & Northern Corp's 13F filing for Q2 2026, filed 17 Jul 2026.